Kent Lake PR’s GeneDx Holdings WGS Stock Holding History

Kent Lake PR’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-169,614	Closed	-$7.2M	–	56
2024 Q3	$7.2M	Buy	+169,614	New	+$5.73M	2.86%	16

Other funds holding WGS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Kent Lake PR's WGS Position: Q4 2024 in Review

Kent Lake PR sold out of GeneDx Holdings (WGS) in Q4 2024, closing a stake of 169,614 shares — an estimated $7.2M sold.

Kent Lake PR first reported a position in WGS in Q3 2024 and held it in 1 quarter. The position peaked at $7.2M in Q3 2024. 199 funds tracked by Wall St. Rank hold WGS as of Q4 2024.

Kent Lake PR reported no remaining GeneDx Holdings position as of Q4 2024 after selling out during the quarter.
Kent Lake PR sold 169,614 GeneDx Holdings shares in Q4 2024, an estimated $7.2M.
Kent Lake PR first reported a position in GeneDx Holdings in Q3 2024 and held it in 1 quarter.
Kent Lake PR's GeneDx Holdings position peaked at $7.2M in Q3 2024.
199 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2024.

Based on Kent Lake PR's 13F filing for Q4 2024, filed 14 Feb 2025.